Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial
Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page
- ChecktodayChange DetectedThe study record history now shows a new revision tag v3.6.4, updating the version from v3.6.3. This indicates an administrative update to the record rather than a change to the study data.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry v3.6.3 has been added to the study record history. It indicates an update to the page version and supersedes the previous v3.6.2 entry.SummaryDifference0.1%

- Check29 days agoChange DetectedA frontend revision label was updated from Revision: v3.6.0 to Revision: v3.6.2 in the page history. This reflects a UI/version update behind the study record history rather than changes to the study information.SummaryDifference0.1%

- Check43 days agoChange DetectedRecruitment status updated to no longer looking for participants, and the revision history now shows a new version (v3.6.0) replacing the previous v3.5.5.SummaryDifference0.3%

- Check50 days agoChange DetectedA new revision entry labeled Revision: v3.5.5 has been added to the history, replacing the prior Revision: v3.5.4. This change updates the study record's history metadata on the Record History page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe release notes now reflect the site version as v3.5.4, replacing the prior v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.